The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N4-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-N2-(3-(piperidin-1-yl)propyl)quinazoline-2,4-diamine ID: ALA5175171
PubChem CID: 168272031
Max Phase: Preclinical
Molecular Formula: C30H42N6O2
Molecular Weight: 518.71
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2nc(NCCCN3CCCCC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
Standard InChI: InChI=1S/C30H42N6O2/c1-37-27-20-25-26(21-28(27)38-2)33-30(31-14-9-17-35-15-7-4-8-16-35)34-29(25)32-24-12-18-36(19-13-24)22-23-10-5-3-6-11-23/h3,5-6,10-11,20-21,24H,4,7-9,12-19,22H2,1-2H3,(H2,31,32,33,34)
Standard InChI Key: SKAXHFHMJFPVDU-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
-3.2145 -0.2070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4999 0.2052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7880 -0.2066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7880 -1.0318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4981 -1.4436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2145 -1.0355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9291 -1.4481 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.6438 -1.0355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0703 -1.4459 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3586 -1.0293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3604 -0.2083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0753 0.2041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0753 1.0294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3607 1.4419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3607 2.2671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3539 2.6797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0684 2.2671 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0685 1.4419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3539 1.0294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7831 2.6797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4978 2.2671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2126 2.6795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9246 2.2675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9246 1.4421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2144 1.0301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4978 1.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3560 -1.4419 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0706 -1.0293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7852 -1.4419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4999 -1.0293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2145 -1.4419 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9291 0.2055 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.6438 -0.2070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9291 -1.0293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6438 -1.4419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6438 -2.2670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9291 -2.6797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2145 -2.2670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
7 8 1 0
4 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
3 12 1 0
12 13 1 0
13 14 1 0
15 14 1 0
16 15 1 0
17 16 1 0
18 17 1 0
19 18 1 0
14 19 1 0
17 20 1 0
20 21 1 0
22 21 2 0
23 22 1 0
24 23 2 0
25 24 1 0
26 25 2 0
21 26 1 0
10 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
1 32 1 0
32 33 1 0
34 31 1 0
35 34 1 0
36 35 1 0
37 36 1 0
38 37 1 0
31 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 518.71Molecular Weight (Monoisotopic): 518.3369AlogP: 5.01#Rotatable Bonds: 11Polar Surface Area: 74.78Molecular Species: BASEHBA: 8HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 9.27CX LogP: 4.01CX LogD: 0.80Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.34Np Likeness Score: -1.20
References 1. Menna M, Fiorentino F, Marrocco B, Lucidi A, Tomassi S, Cilli D, Romanenghi M, Cassandri M, Pomella S, Pezzella M, Del Bufalo D, Zeya Ansari MS, Tomašević N, Mladenović M, Viviano M, Sbardella G, Rota R, Trisciuoglio D, Minucci S, Mattevi A, Rotili D, Mai A.. (2022) Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models., 237 [PMID:35525212 ] [10.1016/j.ejmech.2022.114410 ]